Hinge Health ROE 2026-2025 | HNGE

Current and historical return on equity (ROE) values for Hinge Health (HNGE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Hinge Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.224B $0.000B
Hinge Health Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain and post-surgical rehabilitation. Hinge Health Inc. is based in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.084B 58.67
Tempus AI (TEM) United States $11.897B 0.00
Doximity (DOCS) United States $9.342B 38.47
Hims & Hers Health (HIMS) United States $8.418B 68.48
IRhythm Technologies (IRTC) United States $5.504B 0.00
Privia Health (PRVA) United States $2.884B 180.38
Inspire Medical Systems (INSP) United States $2.509B 41.51
Heartflow (HTFL) United States $2.383B 0.00
10x Genomics (TXG) United States $1.978B 0.00
Enovis (ENOV) United States $1.715B 9.01
Omnicell (OMCL) United States $1.576B 32.22
Azenta (AZTA) United States $1.364B 59.50
Phreesia (PHR) United States $1.304B 0.00
Schrodinger (SDGR) United States $1.299B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Fulgent Genetics (FLGT) United States $0.900B 0.00
Claritev (CTEV) United States $0.715B 0.00
Talkspace (TALK) United States $0.538B 108.33
Butterfly Network (BFLY) United States $0.536B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.477B 0.00
Evolent Health (EVH) United States $0.466B 0.00
Carlsmed (CARL) United States $0.349B 0.00
Zepp Health (ZEPP) Netherlands $0.348B 0.00
TruBridge (TBRG) United States $0.306B 14.05
SOPHiA GENETICS SA (SOPH) Switzerland $0.291B 0.00
CapsoVision (CV) United States $0.239B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.200B 0.00
MDxHealth SA (MDXH) Belgium $0.172B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
Health Catalyst (HCAT) United States $0.160B 0.00
CareCloud (CCLD) United States $0.133B 7.28
EUDA Health Holdings (EUDA) Singapore $0.110B 0.00
Outset Medical (OM) United States $0.085B 0.00
American Well (AMWL) United States $0.066B 0.00
NetraMark Holdings (AINMF) Canada $0.066B 0.00
Pulmonx (LUNG) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
111 (YI) China $0.035B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Precipio (PRPO) United States $0.031B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.025B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00